{
    "body": "Which is the genetic cause for the development of Fanconi anemia complementation group D1?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/15695377", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15645491", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18212739", 
        "http://www.ncbi.nlm.nih.gov/pubmed/14559878", 
        "http://www.ncbi.nlm.nih.gov/pubmed/14695169", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12383764", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16920162"
    ], 
    "ideal_answer": [
        "Fanconi anemia complementation group D1 (FANCD1) was shown to be induced by biallelic mutations in the BRCA2 breast-cancer-susceptibility gene."
    ], 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D051856", 
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D024682", 
        "http://www.uniprot.org/uniprot/BRCA2_MOUSE"
    ], 
    "type": "summary", 
    "id": "54ede34694afd61504000004", 
    "snippets": [
        {
            "offsetInBeginSection": 155, 
            "offsetInEndSection": 327, 
            "text": "The discovery of biallelic BRCA2 mutations in the FA-D1 complementation group allows for the first time to study the characteristics of primary BRCA2-deficient human cells.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16920162", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 383, 
            "offsetInEndSection": 679, 
            "text": "Although he lacked a strong family history of cancer, he was subsequently shown to carry biallelic mutations in the FANCD1/BRCA2 gene. These included an IVS7 splice-site mutation, which is strongly associated with early AML in homozygous or compound heterozygous carrier status in FA-D1 patients.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15645491", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 255, 
            "offsetInEndSection": 317, 
            "text": "Biallelic BRCA2 mutations were shown recently to cause FA-D1. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14695169", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 133, 
            "offsetInEndSection": 265, 
            "text": "The breast cancer susceptibility gene BRCA2 was recently found to be associated with Fanconi anemia complementation group D1 (FA-D1)", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14559878", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 369, 
            "offsetInEndSection": 576, 
            "text": "One kindred, of Ashkenazi Jewish ancestry, had five members who were diagnosed with breast cancer and two cousins who were BRCA2*6174delT/C3069X compound heterozygotes and had Fanconi anemia and brain tumors", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14559878", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 578, 
            "offsetInEndSection": 752, 
            "text": "In another kindred of Ashkenazi Jewish and Lithuanian Catholic ancestry, a child with Fanconi anemia and a medulloblastoma was a BRCA2*6174delT/886delGT compound heterozygote", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14559878", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 754, 
            "offsetInEndSection": 1034, 
            "text": "Two other kindreds each contained a Fanconi anemia-afflicted child who developed medulloblastoma; one child was of Latin American ancestry and a compound heterozygote for BRCA2*I2490T/ 5301insA and the other was African American and a compound heterozygote for BRCA2*Q3066X/E1308X", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14559878", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 256, 
            "text": "Surprisingly, biallelic mutations in the BRCA2 breast-cancer-susceptibility gene were found in Fanconi anemia (FA), a rare hereditary disorder characterized by chromosomal instability, hypersensitivity to DNA cross-linking agents, and cancer susceptibility", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12383764", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 131, 
            "offsetInEndSection": 265, 
            "text": " The breast cancer susceptibility gene BRCA2 was recently found to be associated with Fanconi anemia complementation group D1 (FA-D1).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14559878", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 136, 
            "text": "Biallelic mutations in Fanconi anemia complementation group genes disrupt DNA repair and result in the complex Fanconi anemia phenotype.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15695377", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 141, 
            "offsetInEndSection": 254, 
            "text": "Thirteen complementation groups and genes are identified, including BRCA2, which is defective in the FA-D1 group.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18212739", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 255, 
            "offsetInEndSection": 316, 
            "text": "Biallelic BRCA2 mutations were shown recently to cause FA-D1.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14695169", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 255, 
            "offsetInEndSection": 315, 
            "text": "Biallelic BRCA2 mutations were shown recently to cause FA-D1", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14695169", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 141, 
            "offsetInEndSection": 253, 
            "text": "Thirteen complementation groups and genes are identified, including BRCA2, which is defective in the FA-D1 group", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18212739", 
            "endSection": "abstract"
        }
    ]
}